Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

University of Cincinnati

www.uc.edu

Latest From NantWorks LLC

Cancer “Moonshot” Launch Team Announced: Uncomfortable Ties To Anti-Industry Headlines

The Vice President’s cancer “moonshot” is a great opportunity for biopharma companies to engage in a process that should remind policymakers and the public of the promise of biomedical innovation at a time when the industry’s pricing and financial engineering activities are under scrutiny on Capitol Hill. The selection of the “blue ribbon” panel puts those two images in stark contrast.

BioPharmaceutical Regulation

Start-Up Quarterly Statistics, Q4 2015

Start-ups raised $2.41 billion in Q4 2015. Biopharma companies penned 29 alliances; seven acquisitions were signed in the biopharma and diagnostics industries.

BioPharmaceutical Medical Device

Obama’s Legacy Agenda: Curing Cancer, HIV, Malaria and Addiction – Not Capping Prices

The Administration is actively considering policy options to address prescription drug costs. But the President doesn’t want to be remembered for that.

BioPharmaceutical United States

Obama’s Legacy Agenda: Curing Cancer, HIV, Malaria and Addiction – Not Capping Prices

The Obama Administration is actively considering policy options to address prescription drug costs. But the President doesn’t want to be remembered for that.

BioPharmaceutical Reimbursement
See All
Advertisement
Advertisement
UsernamePublicRestriction

Register